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The major complications of central retinal vein occlusion (CRVO) include neovascularisation and neovascular glaucoma. 1 The development of these complications is considered to be related to ocular ischaemia. Identifying those patients with CRVO who are at high risk of develop ing neovascular complications is important as effective prophylactic treatment with panretinal photocoagulation is available?
Ophthalmic examination (in particular the number of retinal cotton wool spots and the presence of an afferent pupillary defect),3,4 fluorescein angiography5,6 and elec trodiagnostic tests7-9 may be of benefit in helping to pre dict which eyes with CRVO will proceed to neovascular complications.
Systemic associations of CRVO are well described and include hyperlipidaemia, hypertension, diabetes mellitus, hyperproteinaemia and polycythaemia.1()- 14 The develop ment of rubeosis in CRVO has been associated with the presence of systemic hypertension, diabetes mellitus, atherosclerotic cardiovascular disease, ischaemic heart disease, cardiac enlargement, increasing age, and primary open angle glaucoma or ocular hypertension. 15, 16 We reviewed the case notes of all patients attending the Birmingham and Midland Eye Hospital with CRVO in order to determine the presence of any specific underlying medical conditions associated with the development of rubeosis iridis or neovascular glaucoma, and, if possible, to identify a subgroup of CRVO patients at increased risk of developing these neovascular complications.
PATIENTS AND METHODS
All patients with CRVO (n = 235) who attended the medical ophthalmology clinic (E.E.K.) at the Birmingham and Midland Eye Hospital in the 7 year period between 1982 and 1989 have been studied. The diagnosis of CRVO was made clinically, based on the characteristic fundus appearance of a swollen optic disc, engorged retinal veins, and scattered fundus haemorrhages in all quadrants, Oph thalmic examination for all patients included visual acuity assessment, slit lamp examination and applanation tonometry, Gonioscopy was undertaken to detect the pres ence of rubeosis involving the angle, Fluorescein angiog raphy was not routinely performed, For the purpose of this study, rubeosis was defined as the presence of rubeosis iridis with or without neovascular glaucoma.
All patients were referred to the Physicians Clinic (EM,D,) whre a full medical history and clinical examin ation were recorded, Investigations included a full hae matological profile, urea and electrolyte levels, liver function tests, immunoglobulin levels, fasting lipids and blood glucose levels, chest radiograph and electrocar diogram. The blood pressure was recorded after 5 minutes of rest in the sitting and supine positions on an Accuson sphygmomanometer and the mean recorded. The diastolic pressure was recorded at the fifth Korotkoff phase. The appropriate cuff correction for obesity was made. Hypertensive patients were defined, according to World Health Organisation criteria, �s those with a systolic pres sure of greater than 160 mmHg or a diastolic pressure greater than 95 mmHg on three occasions, or those on established antihypertensive drug therapy. Hyperlipidae mia was defined as a fasting serum cholesterol of greater than 6.5 mmol/l or a fasting serum triglyceride of greater than 2.1 mmol/l. Serum cholesterol and triglycerides were measured by standard semi-automated techniques. The electrocardiograms were coded according to a modified Minnesota code.
The patients who developed rubeosis over the 7 year period were individually matched by age (to within 4 years), sex and ethnic origin to patients with CRVO not developing rubeosis. Statistical comparisons for unmatched data were performed using the chi-squared test for prevalence rates and the unpaired (-test for continuous There were no significant differences between the matched groups with respect to age (p = 0.34) or the pro portion of current or ex-smokers (p = 0.42). Weight and the proportion of alcohol drinkers (> 1 unit/day) appeared similar in the two groups although the numbers of both were too small to be tested for statistical significance. The prevalence of hypertension, particularly newly diagnosed hypertension, and of hyperlipidaemia were increased in the group developing rubeosis. Calculation of the relative risks showed an increased risk of developing rubeosis in patients with hypertension [relative risk 2.2, 95% CI (0.7, 6.5)] and hyperlipidaemia [relative risk 1.5, 95% CI (0.5, 4.3)], although these were not found to be statistically significant (p = 0.21 and p = 0.61 respect ively). The prevalence rates of the other medical condi tions were too low to be tested for statistical significance.
The patients with raised immunoglobulin levels in the rubeotic group comprised 2 patients with an elevated IgA (both 4.4 gil; normal range 0.8-4.0 gil), 1 patient with an elevated IgG (17.5 gil; normal range 5.0-14.0 gil), and 1 patient with a combined elevation of IgA (4.4 gil) and IgM (2.5 gil; normal range 0.5-1.9 gil). This last patient had an abnormal immunoglobulin band (lambda), but none of the patients had myeloma.
The Mann-Whitney test was used (on the matched differences) to compare the median biochemical values in the two groups, as the data were not normally distributed and the numbers of matched pairs were, in some cases, small. No significant differences between the matched groups were found. Creatinine levels could not be com pared due to incomplete data.
Medical conditions which were present in the group developing rubeosis are detailed in Table V . Systemic ste roids were being used on a long-term basis by 2 patients, 1 with chronic obstructive airways disease and the other with rheumatoid arthritis. One patient with Eisenmenger's complex had bilateral CRVO with rubeosis. Three patients with mitral valve disease were identified in the rubeotic group, 1 of whom was taking warfarin.
The chest radiograph showed cardiomegaly in 13 patients (41.9%), and the electrocardiogram showed ischaemia in 9 patients (29.0%) in the rubeotic group. Primary open angle glaucoma was present in 3 (9.7%) and ocular hypertension in 2 (6.5%) of the 31 patients develop ing rubeosis.
DISCUSSION
Many previous studies on the investigation of the systemic associations of retinal vein occlusion combined branch and central retinal vein occlusions, which may have differ ent aetiological factors. The neovascular complications in the two groups also differ, with branch retinal vein occlu sions more likely to develop new vessels on the disc or elsewhere and CRVO patients more likely to develop rubeosis iridis or neovascular glaucoma.
I Investigations of CRVO patients developing rubeosis have also produced conflicting results. us Our study considers only CRVO patients, and compares a group developing rubeosis with a carefully matched group with CRVO who did not develop this complication.
The results suggest that increasing age is associated with the development of rubeosis in CRVO. There was no significant difference between the CRVO group with rubeosis and the uncomplicated matched CRVO group in the prevalence rates of hypertension, hyperlipidaemia, diabetes mellitus, median ESR and serum fibrinogen, smoking habits and level of alcohol consumption, indi cating that these are not useful predictive factors for the development of rubeosis in CRVO. Primary open angle glaucoma or ocular hypertension was present in five patients (16.1 %) developing rubeosis, and this association has previously been recognised.
IS There were no cases of rubeosis in the non-Caucasian patients presenting with CRVO, which may be a further manifestation of ethnic differences in this condition.
I?
One of the main problems in CRVO is predicting which eyes are most likely to develop rubeotic complications.
We were unable to demonstrate any specific underlying medical conditions associated with a significant increased risk of developing rubeosis in CRVO. However, special attention should be paid to older subjects presenting with this condition.
